Trusted Content
In a significant reversal, the Centers for Disease Control and Prevention (CDC) has reinstated a $257,000 federal contract for critical research on 9/11-related cancer. The decision follows widespread outrage from lawmakers, advocates, and medical professionals after the Department of Governmental Efficiency (DOGE) initially revoked the funding.
Public and Political Pressure Forces Reinstatement
The abrupt cancellation of funding—intended to study cancer rates among firefighters exposed to toxic debris at Ground Zero—was met with immediate condemnation. New York officials, including Governor Kathy Hochul and Representatives Ritchie Torres and Pat Ryan, denounced the move, calling it a betrayal of the 9/11 first responder community.
Governor Hochul emphasized, “‘Never forget’ isn’t just a slogan—it’s a commitment to those who risked everything and are still paying the price.” Representative Torres called the funding cut “absolutely disgraceful,” while Representative Ryan questioned how the federal government could justify abandoning those who served in the aftermath of the attacks.
Medical experts and first responder organizations echoed these concerns. FDNY Chief Medical Officer David Prezant warned that defunding this research would undermine efforts to track and treat cancers caused by toxic exposure at the World Trade Center site.
What the Reinstatement Means
Under mounting pressure, the CDC reversed its decision, restoring the World Trade Center Health Program (WTCHP)’s funding for this vital research. This reinstatement is more than just a budget correction—it’s a victory for firefighters, first responders, and medical researchers dedicated to understanding the long-term health effects of 9/11-related toxins.
Thursday evening, New York Rep. Nicole Malliotakis posted a statement to social media, saying the White House confirmed that there will be no cuts to staffing at the WTCHP, nor to the research grants necessary to investigate 9/11 illnesses. As of Friday, February 21, 2025, the proposed cuts to WTCHP staff were rescinded.
Beyond the immediate impact, this reversal sends a clear message: public advocacy and political accountability matter. With the funding restored, researchers can continue gathering critical data to ensure first responders receive the care and medical attention they deserve.
The Power of Advocacy
The reinstatement of this 9/11-related cancer research contract proves that advocacy works. It’s a powerful reminder that when voices unite against harmful policy decisions, real change is possible. However, the fight isn’t over—funding for vital medical research must be continuously defended.
First responders and survivors of 9/11 deserve more than just words of gratitude; they deserve action. Ensuring that promises made to these heroes are kept requires persistent pressure and unwavering support.
Contact Pitta & Baione LLP
If you or a loved one is suffering from a 9/11-related health condition, or if you lost someone to a 9/11-related illness, you may be entitled to compensation. The dedicated attorneys at Pitta & Baione LLP are here to help. Contact us today for a free consultation.
